EP0868477B1 - Fluorierte oniumsatze, härtbare zusammensetzungen, welche selbige enthalten, und härtungsverfahren unter deren verwendung - Google Patents

Fluorierte oniumsatze, härtbare zusammensetzungen, welche selbige enthalten, und härtungsverfahren unter deren verwendung Download PDF

Info

Publication number
EP0868477B1
EP0868477B1 EP96941490A EP96941490A EP0868477B1 EP 0868477 B1 EP0868477 B1 EP 0868477B1 EP 96941490 A EP96941490 A EP 96941490A EP 96941490 A EP96941490 A EP 96941490A EP 0868477 B1 EP0868477 B1 EP 0868477B1
Authority
EP
European Patent Office
Prior art keywords
group
formula
onium
cure
cure accelerator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP96941490A
Other languages
English (en)
French (fr)
Other versions
EP0868477A1 (de
Inventor
William D. Coggio
Dirk H. C. Arren
Douglas S. Parker
Allan T. Worm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of EP0868477A1 publication Critical patent/EP0868477A1/de
Application granted granted Critical
Publication of EP0868477B1 publication Critical patent/EP0868477B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages

Definitions

  • This invention relates to curing vinylidene fluoride-containing fluoropolymer compositions.
  • Fluoropolymers containing vinylidene fluoride units have particular utility in high temperature applications, including seals, gaskets, and linings, as described, for example, in Brullo, R.A., ''Fluoroelastomer Rubber for Automotive Applications," Automotive Elastomer & Design, June 1985, “Fluoroelastomer Seal Up Automotive Future,” Materials Engineering , October 1988, and “Fluorocarbon Elastomers,” Encyclopedia of Polymer Science and Engineering , vol. 7, pp. 257 et seq.
  • the cured polymers generally adhere to the surface of the mold.
  • a shaped article prepared from the fluoropolymer is frequently torn or damaged when removed from the mold.
  • the incorporation of a mold release agent into the polymer can have serious adverse effects on the physical properties of the cured composition (e.g., Mooney Scorch, shrinkage, and compression set) which can limit the successful commercial use of the cured composition.
  • Deposits of polymer on the mold cavity surface ("mold fouling") and poor release of the shaped, cured article from the mold are major reasons for defects, resulting in rejection of the article (which then adds to the expense of manufacturing such articles).
  • Kolb describes compositions containing a phosphonium or ammonium salt, a sulfonium compound, and (optionally) a polyhydroxy compound that are designed to perform the dual functions of accelerating fluoropolymer cure and providing mold release properties.
  • the invention features a class of compounds useful, e.g., as cure accelerators for vinylidene fluoride-containing polymers having the formula: where Q is an onium ion; A - is a counterion; R 1 , R 2 , R 3 , and R 4 , independently, comprise (a) a non-fluorinated alkyl (e.g., a branched or straight chain alkyl group such as methyl, ethyl, propyl, butyl, or iso-butyl), cycloalkyl (e.g., cyclohexyl), allyl, aryl (e.g., phenyl), or aralkyl (e.g., benzyl) group; (b) an onium-containing group; or (c) a group having the formula -(CH 2 ) n -Y-R 5 in which n is at least two; Y is a group selected from -CH 2 -,
  • At least one of the R 1 , R 2 , R 3 , and R 4 groups comprises (1) an alkyl group having at least four carbon atoms; (2) a group having the formula -(CH 2 ) n -O-R 5 ; or (3) a group having the formula -(CH 2 ) n -Ph-O-SO 2 -R 5 where Ph is a phenyl group.
  • the R 5 group preferably is (1) a perfluorinated alkyl group; (2) a perfluorinated ether group having the formula: in which p is greater than or equal to zero with the proviso that when Y is -O- p is greater than or equal to one, m is greater than or equal to one, x is greater than or equal to two, R f is a perfluoroalkyl group (e.g., a C 1 -C 6 perfluorinated alkyl group such as a perfluorinated methyl group), and R f' is F or a perfluoroalkyl group (e.g., a C 1 -C 6 perfluorinated alkyl group such as a perfluorinated methyl group); or (3) a fluorinated alkyl group having the formula -CH 2 -(CF 2 ) x -H in which x is at least four.
  • Preferred onium ions include phosphonium, ammonium, and
  • One example of a preferred compound has the formula
  • a second example of a preferred compound has the formula:
  • a third example of a preferred compound has the formula:
  • a fourth example of a preferred compound has the formula:
  • a fifth example of a preferred compound has the formula:
  • a sixth example of a preferred compound has the formula:
  • the invention also features a method of curing a polymer comprising vinylidene fluoride units using the above-described cure accelerators, as well as curable compositions comprising such polymers and the above-described cure accelerators.
  • cure is conducted in the absence of mold release agents.
  • the invention provides curable compositions with rapid cure times in which cure time is decreased by means of a fluorinated onium cure accelerator.
  • the fluorinated onium cure accelerator itself also provides good mold release properties, thereby dispensing with the need for separate mold release agents.
  • the resulting cured articles exhibit good physical properties.
  • Curable vinylidene fluoride-containing fluoropolymer compositions according to the invention contain a fluorinated onium salt as a cure accelerator.
  • a fluorinated onium salt as a cure accelerator.
  • the counterion A - may be an organic or inorganic anion, e.g., halide, thiosulfate, formate, cyanate, thiocyanate, tetraphenylborate, perchlorate, nitrate, tetrafluoroborate, hexafluorophosphate, oxalate, stearate, haloacetate, para-toluenesulphonate, ZnCl 4 2- , CdCl 4 2- , NiBr 4 2- , HgI 3 - , sulfate, acetate, phosphate, phosphonate, hydroxide, alkoxide, phenoxide, trifluoromethane sulfonate,
  • the R 1 to R 4 and R 6 groups are preferably selected from the group of radicals consisting of alkyl, aryl, allyl, and alkenyl radicals, or combinations thereof
  • the R groups may be unsubstituted or substituted with one or more neutral, nonfunctional substituents that are non-ionizable under conditions of compounding or cure.
  • substituents include, e.g., halogen atoms, cyano, -OR', and -COOR' moieties where R' is selected from the group of radicals consisting of C 1 -C 20 alkyl, aryl, aralkyl, and alkenyl radicals.
  • any pair of R groups can be connected with each other and the onium ion to form a heterocyclic ring.
  • the R 5 group is a fluorinated alkyl or alkoxy group.
  • the fluorinated onium salts are generally prepared by reacting, e.g., a phosphine, amine, or sulfide with an alkylating agent, resulting in the expansion of the valence of the electron donating phosphorous, nitrogen, or sulfur atom and a positive charge on the organo-onium.
  • curable vinylidene fluoride-containing polymers are described in the aforementioned Kolb patent; Worm, U.S. Pat. No. 4,233,421; and Grootaert et al., U.S. Pat. No. 4,882,390.
  • Fluorine-free terminally unsaturated monoolefin monomers e.g., ethylene or propylene, may also be used as co-monomers.
  • Fillers are often added to the polymers discussed above to improve the physical properties of the cured composition or vulcanizate.
  • a filler When a filler is employed, it is added to the vulcanization recipe in amounts of up to about 100 parts per hundred parts by weight of polymer, preferably between about 1 and 50 parts per hundred parts by weight of the polymer.
  • fillers which may be used are reinforcing thermal grade carbon blacks or non-black pigments of relatively low reinforcement characteristics such as clays, barytes, etc.
  • the curable composition preferably contains a crosslinking agent as well.
  • a crosslinking agent is well known and are described in the art, e.g., in the aforementioned Kolb and Worm patents, and in U.S. Pat. Nos. 4,259,463 (Moggi et al.), 3,876,654 (Pattison), and 5,384,374 (Guerra et al.), and can include aromatic polyhydroxy compounds, aliphatic polyhydroxy compounds, and derivatives thereof. Blends may be used as well.
  • Preferred polyhydroxy compounds are aromatic polyhydroxy compounds such as isopropylidene-bis(4-hydroxy-benzene) (“bisphenol A”) and hexafluoro-isopropylidenebis(4-hydroxybenzene) (“bisphenol AF").
  • Fluoroaliphatic sulfonamides can also be added, including those of the formula R f SO 2 NHR", where R" is a hydrogen atom or alkyl radical having, for example, from 1 to 20 carbon atoms, preferably from 1 to 12 carbon atoms, R f is a fluoroaliphatic radical such as a perfluoroalkyl, e.g., C n F 2n+1 where n is 1 to 20, or perfluorocycloalkyl, e.g., C n F 2n-1 where n is 3 to 20, such compounds being described, for example, in U.S. Pat. No. 5,086,123 (Guenther et al.).
  • the fluoroaliphatic sulfonamide is preferably a perfluoroalkylsulfonamide and may be added as a separate compound, or as the anion of the organo-onium compound.
  • the fluorinated cure accelerators and crosslinking agent can be added to the uncured polymer gum in the form of finely divided solids or as solutions in alcohol or ketone solvents by mixing the materials into the polymer gum stock.
  • the gum stock can generally be stored at room temperature for extended periods, e.g., up to two years or more.
  • Acid acceptors Prior to curing, an acid acceptor is mixed into the gum stock, after which storage life of the stock is more limited.
  • Acid acceptors can be inorganic or organic.
  • Organic acceptors include epoxies, sodium stearate, and magnesium oxalate.
  • inorganic acceptors include magnesium oxide, lead oxide, calcium oxide, calcium hydroxide, dibasic lead phosphite, zinc oxide, barium carbonate, strontium hydroxide, calcium carbonate, etc.
  • the preferred acid acceptors are magnesium oxide and calcium hydroxide.
  • the acid acceptors can be used singly or in combination, and preferably are used in amounts ranging from about 2 to 25 parts per 100 parts by weight of the polymer. All of the components of the curing system may be admixed prior to their incorporation into the polymer gum without departing from the scope of the invention.
  • the relative amounts of the crosslinking agent and fluorinated onium salt are present in the composition in such amounts as to provide the desired cure and/or mold release of the composition when mixed with acid acceptor.
  • Representative proportions of components of the curing system are as follows:
  • the desired amount of acid acceptor, fluorinated onium salt, crosslinking agent, diorgano sulfur oxide compounds (if any), and other conventional adjuvants or ingredients are added to the unvulcanized polymer (i.e. gum stock) and intimately admixed therewith or compounded by employing any of the usual rubber mixing devices such as Banbury mixers, roll mills, or any other convenient mixing device.
  • the temperature of the composition during mixing should not rise above about 120°C. During mixing it is necessary to distribute the components and adjuvants uniformly throughout the curable polymer.
  • the curing process typically comprises molding the resulting composition under pressure at a temperature ranging from about 95°C to about 230°C, followed by curing.
  • the composition of this invention is particularly useful for injection molding.
  • the molded product is then usually post cured (e.g., oven cured) at a temperature between about 150°C and about 315°C, usually at about 232°C, for a period of from about 2 hours to 50 hours or more depending on the cross-sectional thickness of the sample.
  • the precursor fluoroalkyl phosphines used for the preparation of cure accelerators according to the invention were prepared via free radical hydrophosphorylation reaction between diisobutylphosphine (DIBP) and a fluoroalkyl allyl ether or an allyl fluorosulfonamide.
  • DIBP diisobutylphosphine
  • Such hydrophosphorylation reactions are well-known in the art.
  • t S 2 the time to a 2 unit rise in torque from M L
  • t'50 the time to increase torque above M L by 50% of delta torque
  • t'90 the time to increase torque above M L by 90% of delta torque
  • Press-Cure data were obtained from 20 X 20 X 0.2 cm sheets prepared by pressing a sample of the curable compositions at about 6.9 MPa for 10 min. at 177°C.
  • Post-Cure data were obtained from sheets prepared as described above which were then further treated or cured by heating the sheets in a circulating air oven maintained at about 232°C for 16 hours.
  • Tensile strength at break, elongation at break and stress at 100% elongation were determined using a Monsanto mechanical tester with a 200 1b (88.9 kg) load cell in accordance with ASTM D 412-92 ⁇ 1 . Test specimens were cut from the press- or post-cured sheets using Die D. A 1" (25.4 mm) gage section was used to follow the cross head displacement. All tests were run at a constant crosshead displacement rate of 20"/minute (508 mm/min.) in triplicate. The values reported were averages of the three tests. Stress at 100% elongation, elongation at break, and tensile strength at break were reported in units of mega Pascals (MPa), %, and MPa, respectively.
  • MPa mega Pascals
  • the mold used to make O-rings was a 4 cavity mold with O-ring internal diameter of 48 mm, O-ring cross-section of 2.90 mm, a runner length of 13 mm, sprue base diameter of 5.2 mm, sprue length of 29 mm, and each cavity had a vacuum canal.
  • the mold steel was STAVAX ESR with a surface finish EDM.
  • the mold was conditioned before each experiment (change of formulation) by blasting the mold surface with 50-150 micron glass beads under 0.2 MPa pressure for 10 minutes. The mold was then conditioned for 30 minutes in a water-based caustic solution at 80°C and then ultrasonically cleaned in the solution for 10 minutes. After cleaning, the mold was rinsed with deionized water, dried and stored overnight before use. Multiple molding cycles were made of each formulation.
  • the steady state O-ring injection molding conditions were 190°C mold temperature, 95°C injection barrel temperature, 60°C screw barrel temperature, injection speed 60% of maximum, after-injection pressure of 5.5 MPa for 2 seconds, screw RPM 35% of maximum, backpressure of 0.5 MPa, plastication delay of 2 seconds after end holding time and a vacuum time of 2.5 seconds.
  • the holding time and heating time were both dependent upon vulcanization speed and were adjusted to obtain cured O-rings.
  • the shot size was adjusted to give similar flash to the parts molded.
  • Precursor fluoroalkyl phosphines or amides used in the preparation of the fluorinated onium cure accelerators of the invention were prepared as described below.
  • Phosphine A 3-(1,1-dihydroperfluorooctyloxy)propyl diisobutylphosphine (Phosphine A) was prepared in a 1000 mL, 4 neck flask, equipped with an overhead stirrer, a condenser, nitrogen purge adapter, thermometer and rubber septum by charging 170 g of a 70% solids solution in toluene (0.82 mol) of diisobutyl phosphine (DIBP), available from Cytec Industries, Inc. The flask assembly was placed on an adjustable lab jack so that either external heating or cooling of the reaction flask could be done. Additional toluene was added to dilute the DIBP solution to about 50% solids. The reaction flask was purged with nitrogen for fifteen minutes and a positive stream of nitrogen was maintained through the reaction flask to minimize the oxidation of the DIBP.
  • DIBP diisobutyl phosphine
  • Phosphine B 3-(1,1-dihydroperfluoropropoxy) propyl diisobutylphosphine
  • Phosphine B was prepared in a three neck round bottomed flask equipped with a magnetic stir bar, reflux condenser, addition funnel and a nitrogen purge inlet by charging 28.3 g (1.23 mol) Sodium metal and then adding 500 ml of dry tetrahydrofuran to disperse the sodium metal.
  • the addition funnel was charged with a solution of dry THF in which was dissolved 188 g (1.25 mol) of pentafluoropropanol, available from Aldrich Chemical Company, Inc.
  • the pentafluoropropanol solution was added slowly to the sodium metal at a rate sufficient enough to maintain a reaction temperature of about 40 to 50°C.
  • the 3-(1,1-dihydroperfluoropropoxy) propyl diisobutylphosphine was then prepared in a manner similar to the preparation described for Phosphine A except that 3-(1,1-dihydropentafluoropropyl) allyl ether was used in the hydrophosphorylation reaction.
  • Phosphine C Bis(3-(1,1-dihydroperfluoropropoxy)propyl) isobutyl phosphine
  • Phosphine D N-ethyl, N-(3-diisobutyl phosphino)propyl perfluoro octane sulfonamide
  • the starting allyl sulfonamide was not completely consumed by the DIBP after 60 hrs at 100 °C.
  • a 31 P NMR spectrum of the reaction mixture after 60 hrs of reaction time showed that approximately 35% of the desired phosphine formed.
  • the flask was charged with 38 g (0.26 mol) of DIBP.
  • the reaction mixture was heated at this temperature for an additional 60 hrs. The progress of the reaction was monitored by gas chromatography and 31 P NMR spectroscopy. After this time period, the toluene solvent and unreacted DIBP were removed by simple distillation under reduced pressure (40 to 80°C @ 1 mmHg).
  • Example 1 a fluorinated phosphonium cure accelerator of the present invention was prepared in a 200 ml airless flask equipped with a nitrogen purge inlet and a magnetic stir bar by charging 50 g (0.085 mol) of Phosphine A [3-( 1,1-dihydroperfluorooctyloxy)propyl diisobutylphosphine) to the flask. Next, 20 ml of 2-propanol was added to the flask to dissolve Phosphine A, and 10.8 g of benzyl chloride (0.085 mol), available from Aldrich Chemical Co., was added to the phosphine solution. The resulting mixture was heated to about 50°C for 12 hrs.
  • 31 P NMR spectroscopy of the reaction mixture showed that the phosphine had been quantitatively converted to the trialkyl benzyl phosphonium halide.
  • the 2-propanol was removed under vacuum and the product (3-(1,1-dihydroperfluorooctyloxy)propyl diisobutyl benzyl phosphonium chloride) was dried further under vacuum for about 12 hrs at 50 C. 1 H, 31 P and 19 F NMR spectra confirmed the structure of the desired product.
  • fluorinated phosphonium cure accelerators of the invention were made in a manner similar to Example 1 except Phosphine B was used in Example 2 instead of Phosphine A, Phosphine C was used in Example 3, and Phosphine D was used in Example 4.
  • 2-((3-diisobutyl benzyl phosphonium chloride)propyl)phenyl perfluorooctane sulfonate was made by first preparing 3-(2-hydroxyl phenyl)propyl diisobutyl phosphine in a manner similar to Phosphine A except using 2-allyl phenol and DIBP.
  • a 3-neck reaction vessel equipped with condenser, mechanical stirrer and an addition funnel was then charged with 3.6 g (0.09 mol) of NaH, 60% dispersion in mineral oil, and 350 mL of dry THF.
  • the reaction mixture was worked up by extraction of the product mixture with water and methylene chloride. The organic layers were combined and dried with MgSO 4 and the solvent was removed under reduced pressure. The product was isolated as a viscous, light brown oil, 61.6 g (88% yield). Characterization by 1 H, 31 P, 19 F NMR spectroscopy confirmed the proper structure of the product.
  • the phosphonium product was isolated by removal of the solvent by rotoevaporation followed by further drying under vacuum at room temperature.
  • the ingredients used in each curable composition were mixed on a two-roll mill using standard methods.
  • the polyhydroxy crosslinking agent, 4,4'-(hexafluoroisopropylidene) diphenol (bisphenol AF), and calcium hydroxide are commercially available from Aldrich Chemical Company, Inc.
  • Magnesium oxide is available as "Maglite D”
  • carbon black is available as "Thermax MT, ASTM N990.” Amounts of the reagents are listed in pans per hundred rubber, (pphr) or mmoles per hundred parts rubber, (mmhr).
  • Example 7 a curable composition of the invention was prepared by mixing the following ingredients together on a conventional two-roll mill using standard methods: 100 g of a fluorine-containing copolymer of vinylidene fluoride (60 wt%) and hexafluoropropylene (40 wt%), available from 3M Co. as FluoretTM Fluoroelastomer FC-2145, 2.1 g (6.1 mmol) of bisphenol-AF and a methanol solution (about 50% solids) of 0.92 g (1.29 mmhr) of the fluorinated onium cure accelerator prepared above as Example 1.
  • FluoretTM Fluoroelastomer FC-2145 2.1 g (6.1 mmol) of bisphenol-AF and a methanol solution (about 50% solids) of 0.92 g (1.29 mmhr) of the fluorinated onium cure accelerator prepared above as Example 1.
  • a press-cured sheet was prepared by pressing a quantity of the curable composition at about 6.9 MPa at 177°C for 10 minutes. The resulting press-cured sheet was evaluated for physical properties. A sample of the press-cured sheet was further treated or cured for 16 hours at 232°C, resulting in a post-cured sheet which was also evaluated for physical properties. The press-cured and post-cured sheet test results are reported in Tables 2 and 3.
  • Example 8-11 curable compositions of the invention were prepared and evaluated in a manner similar to Example 7 except the fluorinated onium cure accelerator used was varied as follows: Example 8 used the compound prepared above as Example 2, Example 9 was prepared using the compound prepared above as Example 3, Example 10 was prepared using the compound prepared above as Example 4, and Example 11 was prepared using the compound prepared above as Example 5. Data are reported in Tables 1-4.
  • Example 12 The curable fluoroelastomer composition of Example 12 was prepared and evaluated in a manner similar to Example 7 except the fluorinated onium cure accelerator used was varied as follows: the phosphonium compound described in Example 6 was used and 0.662 phr (1 mmhr) of onium was used instead of 1.29 mmhr. Data are reported in Tables 1-5.
  • Comparative Example C1 a curable composition was prepared and evaluated as in Example 7 except the onium cure accelerator used was benzyltriphenyl phosphonium chloride, a commonly used cure accelerator commercially available from Aldrich Chemical Company, Inc.
  • a curable composition was prepared and evaluated as in Example 7 except the onium cure accelerator used, N-3-(diisobutyl benzyl phosphonium chloride) propyl perfluorooctanoic acid amide, was prepared in a one neck, airless flask, equipped with a magnetic stir bar, a nitrogen inlet adapter and a rubber septum into which was charged 28.5 g (0.067 mol) of methyl perfluorooctanoate, available from PCR Corp.
  • the onium cure accelerator used N-3-(diisobutyl benzyl phosphonium chloride) propyl perfluorooctanoic acid amide
  • the perfluorooctanoate was cooled to 0°C, and 12.8 g (0.063 mol) of 3-aminopropyl diisobutylphosphine was added via a syringe. The resulting mixture was stirred at 0°C for 1 to 1.5 hrs. An infrared spectrum of the reaction mixture showed that the methyl ester carbonyl stretch at 1790 cm -1 was absent and a new carbonyl stretch at 1700 to 1710 cm -1 was present. In addition, a gas chromatograph of the product mixture confirmed that one new product had formed.
  • reaction mixture was warmed to about 45°C, diluted to about 50% solids with methanol and then 7.9 g (0.063 mol) of benzyl chloride was added and the reaction was continued for 12 hrs.
  • a 31 P NMR spectrum of the reaction mixture consisted of only a singlet at +30 ppm suggesting that complete consumption ofthe phosphine had occurred.
  • the product a highly viscous, light brown oil, was isolated by solvent removal and drying the product under vacuum. The product was characterized by P, 1 H and 19 F NMR spectroscopy.
  • Comparative Example C3 a curable composition was prepared and evaluated as in Example 7 except the onium cure accelerator used was prepared in a manner similar to the onium cure accelerator in Comparative Example C2 except methyl perfluoro butoxy ethoxy ethanoate was used instead of methyl perfluorooctanoate.
  • Compression set data were obtained using ASTM method D-395-89. O-rings were press cured for 12 min. at 177°C and post cured for 16 hrs at 232°C. O-rings were compressed 25% for 70 hrs at 200°C. Data (shown in Table 4) are reported as percent of the compression remaining after the tests.
  • Example 13 a curable composition of the invention was made in a manner similar to Example 7 except that the fluorine-containing copolymer used was prepared as described by Example 3 of U.S. Pat. No. 5,285,002 (Grootaert).
  • Comparative Example C4 a curable composition was made in a manner similar to Comparative Example C I except that the fluorine-containing copolymer used was prepared as described by Example 3 of U.S. Pat. No. 5,285,002 (Grootaert).
  • Table 5 show an improved mold release rating when using a fluorinated onium cure accelerator of the invention compared to a currently used commercial onium cure accelerator.
  • fluorinated onium cure accelerators of the invention show a combination of rapid cure rates, no loss in physical properties, and improved injection molding release properties and generally improved compression set properties relative to the Comparative Examples evaluated.
  • Example 14 a curable composition of the invention was made and evaluated as in Example 7 except 100 g of a fluorine-containing terpolymer was used instead of FluorelTM fluoroelastomer FC-2145.
  • the specific terpolymer used was made as described in Example 5 of U.S. Pat. No. 5,285,002 (Grootaert).
  • 0.42 g (1.25 mmhr) of bisphenol-AF was reacted with the fluorinated onium cure accelerator by reacting the fluorinated phosphonium chloride (prepared as Example 1) with the sodium salt of bisphenol AF (prepared as described in Example 22 of U.S. Pat. No. 4,912,171 (Grootaert et al)).
  • Comparative Example C5 a curable composition was made and evaluated in a manner similar to Example 14 except the onium cure accelerator used was tributyl methoxy propyl phosphonium chloride, prepared as described in Example 16 of U.S. Pat. No. 4,912,171 (Grootaert et al).
  • Comparative Example C6 a curable composition was made and evaluated in a manner similar to Example 14 except the onium cure accelerator used was the fluoroalkyl amide onium described in comparative example C2.
  • Compression set data were obtained using ASTM method D-395-89. O-rings were press cured for 12 min. at 177°C and post cured for 16 hrs at 232°C. O-rings were compressed 25% for 70 hrs at 200°C. Data (shown in Table 10) are reported as percent of the compression remaining after the tests.
  • Table 11 show an improved mold release rating when using a fluorinated onium cure accelerator of the invention compared to other onium cure accelerators.
  • fluorinated onium cure accelerators of the invention show a combination of rapid cure rates, no loss in physical properties, and improved injection molding release properties and generally improved compression set properties relative to the Comparative Examples evaluated.

Landscapes

  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Claims (7)

  1. Härtbare Zusammensetzung umfassend:
    (a) mindestens ein härtbares Polymer, das Vinylidenfluorid-Einheiten umfasst; und
    (b) mindestens einen Härtungsbeschleuniger mit der Formel
    Figure 00340001
    wobei Q ein Onium-Ion ist; A- ein Gegenion ist; R1, R2, R3 und R4 unabhängig voneinander (a) einen nicht fluorierten Alkyl-, Cycloalkyl-, Allyl-, Aryl- oder Aralkyl-Rest; (b) eine Onium enthaltende Gruppe; oder (c) eine Gruppe mit der Formel -(CH2)n-Y-R5 umfassen, in welcher n mindestens zwei ist; Y eine aus -CH2-, -O-, -OCH2-, -S-, -SO2- oder -Z-SO2- ausgewählte Gruppe ist; Z eine -R6-O-, -N(R7)- oder -N(H)-Gruppe ist; R6 ein substituierter oder unsubstituierter Phenylen-Rest ist; R7 ein nicht fluorierter Alkyl-, Cycloalkyl-, Allyl-, Aryl- oder Alkaryl-Rest ist; und R5 ein fluorierter Alkyl- oder Alkoxy-Rest ist,
    mit der Maßgabe, dass (i) mindestens einer der Reste R1, R2, R3 und R4 eine Gruppe mit der Formel -(CH2)n-Y-R5 umfasst; (ii) die Gesamtzahl der Fluoratome in dem Härtungsbeschleuniger mindestens 5 ist; und (iii) wenn Q ein Sulfonium-Ion ist, kein R4-Rest vorhanden ist.
  2. Verfahren zum Härten eines Vinylidenfluorid-Einheiten umfassenden Polymers, umfassend das Kombinieren des Polymers mit einem Härtungsbeschleuniger, der die Formel:
    Figure 00350001
    besitzt,
    wobei Q ein Onium-Ion ist; A- ein Gegenion ist; R1, R2, R3 und R4 unabhängig voneinander (a) einen nicht fluorierten Alkyl-, Cycloalkyl-, Allyl-, Aryl- oder Aralkyl-Rest; (b) eine Onium enthaltende Gruppe; oder (c) eine Gruppe mit der Formel -(CH2)n-Y-R5 umfassen, in welcher n mindestens zwei ist; Y eine aus -CH2-, -O-, -OCH2-, -S-, -SO2- oder -Z-SO2- ausgewählte Gruppe ist; Z eine -R6-O-, -N(R7)- oder -N(H)-Gruppe ist; R6 ein substituierter oder unsubstituierter Phenylen-Rest ist; R7 ein nicht fluorierter Alkyl-, Cycloalkyl-, Allyl-, Aryl- oder Alkaryl-Rest ist; und R5 ein fluorierter Alkyl- oder Alkoxy-Rest ist, mit der Maßgabe, dass (i) mindestens einer der Reste R1, R2, R3 und R4 eine Gruppe mit der Formel -(CH2)n-Y-R5 umfasst; (ii) die Gesamtzahl der Fluoratome in dem Härtungsbeschleuniger mindestens 5 ist; und (iii) wenn Q ein Sulfonium-Ion ist, kein R4-Rest vorhanden ist.
  3. Verfahren nach Anspruch 2, umfassend das Härten des Polymers in Abwesenheit eines Formtrennmittels.
  4. Zusammensetzung oder Verfahren nach einem der vorhergehenden Ansprüche, wobei mindestens einer der Reste R1, R2, R3 und R4 des Härtungsbeschleunigers eine Gruppe umfasst, die aus einer Alkylgruppe mit mindestens vier Kohlenstoffatomen; einer Gruppe mit der Formel -(CH2)n-O-R5, oder einer Gruppe mit der Formel - (CH2)n-Ph-O-SO2-R5 ausgewählt ist.
  5. Zusammensetzung oder Verfahren nach einem der vorhergehenden Ansprüche, wobei der Rest R5 des Härtungsbeschleunigers als eine perfluorierte Alkylgruppe; eine fluorierte Alkylgruppe mit der Formel -CH2-(CF2)x-H, in welcher x mindestens vier ist; oder eine perfluorierte Ethergruppe mit der Formel:
    Figure 00360001
    in welcher p größer oder gleich Null ist, ausgewählt ist, mit der Maßgabe, dass wenn Y -O- ist, p größer oder gleich eins ist, m größer oder gleich eins ist, x größer oder gleich zwei ist, Rf eine Perfluoralkylgruppe ist, und Rf, F oder eine Perfluoralkylgruppe ist.
  6. Zusammensetzung oder Verfahren nach einem der vorhergehenden Ansprüche, wobei das Onium-Ion des Härtungsbeschleunigers ein Phosphonium-, Ammonium- oder Sulfonium-Ion umfasst.
  7. Zusammensetzung oder Verfahren nach einem der Ansprüche 1 bis 6, umfassend einen Härtungsbeschleuniger, der aus der Gruppe von Beschleunigern mit der Formel:
    Figure 00360002
    Figure 00370001
    Figure 00370002
    Figure 00370003
    Figure 00370004
    und
    Figure 00380001
    ausgewählt ist.
EP96941490A 1995-12-21 1996-11-26 Fluorierte oniumsatze, härtbare zusammensetzungen, welche selbige enthalten, und härtungsverfahren unter deren verwendung Expired - Lifetime EP0868477B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US576097 1984-02-01
US08/576,097 US5591804A (en) 1995-12-21 1995-12-21 Fluorinated onium salts, curable compositions containing same, and method of curing using same
PCT/US1996/018936 WO1997023556A1 (en) 1995-12-21 1996-11-26 Fluorinated onium salts, curable compositions containing same, and method of curing using same

Publications (2)

Publication Number Publication Date
EP0868477A1 EP0868477A1 (de) 1998-10-07
EP0868477B1 true EP0868477B1 (de) 2004-08-11

Family

ID=24302974

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96941490A Expired - Lifetime EP0868477B1 (de) 1995-12-21 1996-11-26 Fluorierte oniumsatze, härtbare zusammensetzungen, welche selbige enthalten, und härtungsverfahren unter deren verwendung

Country Status (7)

Country Link
US (1) US5591804A (de)
EP (1) EP0868477B1 (de)
JP (1) JP3723221B2 (de)
AU (1) AU1061797A (de)
CA (1) CA2238941C (de)
DE (1) DE69633135T2 (de)
WO (1) WO1997023556A1 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891965A (en) * 1997-01-06 1999-04-06 Dyneon Llc Low temperature perfluoroether-containing fluoroelastomers
US5728773A (en) * 1997-02-21 1998-03-17 Minnesota Mining And Manufacturing Company Fluoroelastomer composition with organo-onium and blocked-carbonate compounds
US6096428A (en) * 1998-04-09 2000-08-01 3M Innovative Properties Company Multi-layer compositions comprising a fluoropolymer
US6156400A (en) * 1998-04-09 2000-12-05 3M Innovative Properties Company Multi-layer compositions comprising a fluoropolymer
US6326436B2 (en) 1998-08-21 2001-12-04 Dupont Dow Elastomers, L.L.C. Fluoroelastomer composition having excellent processability and low temperature properties
US6329469B1 (en) 1998-08-21 2001-12-11 Dupont Dow Elastomers, L.L.C. Fluoroelastomer composition having excellent processability and low temperature properties
WO2000052084A1 (en) 1999-03-02 2000-09-08 3M Innovative Properties Company Compositions for fluoropolymer bonding to non-fluorinated polymers
US6465576B1 (en) 1999-07-02 2002-10-15 Dyneon Llc Fluoroelastomer compositions and articles made therefrom
US6359166B1 (en) 1999-10-08 2002-03-19 3M Innovative Properties Company Oxalate ester blocked phenols
US6767948B1 (en) * 1999-12-22 2004-07-27 3M Innovative Properties Company Polyolefin polymer and catalyst blend for bonding fluoropolymers
US6720360B1 (en) * 2000-02-01 2004-04-13 3M Innovative Properties Company Ultra-clean fluoropolymers
US6593416B2 (en) 2000-02-01 2003-07-15 3M Innovative Properties Company Fluoropolymers
IT1318487B1 (it) 2000-04-21 2003-08-25 Ausimont Spa Fluoroelastomeri.
IT1318488B1 (it) * 2000-04-21 2003-08-25 Ausimont Spa Fluorovinileteri e polimeri da essi ottenibili.
US7534845B2 (en) 2000-04-21 2009-05-19 Solvay Solexis S.P.A. Fluorovinyl ethers and polymers obtainable therefrom
EP1167441B1 (de) * 2000-06-29 2015-07-29 3M Innovative Properties Company Mineralöl enthaltende Fluoroelastomerzusammensetzung
US6890995B2 (en) * 2001-01-31 2005-05-10 3M Innovative Properties Company Fluoropolymer compositions
US6803425B2 (en) 2001-04-12 2004-10-12 3M Innovative Properties Company Fluoropolymers having pendant imidate structures
US6844388B2 (en) 2001-04-12 2005-01-18 3M Innovative Properties Company Fluoropolymer compositions containing a nitrogen cure site monomer
US6794457B2 (en) 2001-04-30 2004-09-21 3M Innovative Properties Company Fluoropolymer curing system containing a nitrogen cure site monomer
CN1290880C (zh) * 2001-05-02 2006-12-20 3M创新有限公司 制备氟聚合物的无乳化剂水乳液聚合方法
JP4624646B2 (ja) * 2001-05-02 2011-02-02 スリーエム イノベイティブ プロパティズ カンパニー フルオロポリマーを製造するための連鎖移動剤としてのエーテルの存在下での水性乳化重合
WO2003037621A2 (en) * 2001-10-31 2003-05-08 3M Innovative Properties Company Bonding of a fluoropolymer layer to a substrate
US6916871B2 (en) * 2001-10-31 2005-07-12 3M Innovative Properties Company Composition and method for making a fluoroelastomer
US20040114772A1 (en) * 2002-03-21 2004-06-17 David Zlotnick Method and system for transmitting and/or receiving audio signals with a desired direction
ITMI20020598A1 (it) 2002-03-22 2003-09-22 Ausimont Spa Fluoroelastomeri vulcanizzabili
RU2004135531A (ru) * 2002-06-21 2005-07-10 ЗМ Инновейтив Пропертиз Компани (US) Процесс получения фторполимеров с пониженным содержанием полярных концевых групп
US6884860B1 (en) 2002-07-29 2005-04-26 3M Innovative Properties Company Fluoroelastomer copolymer based on tetrafluoroethylene, chlorotrifluoroethylene, hexafluoropropylene and vinylidene fluoride
US7064170B2 (en) * 2002-10-31 2006-06-20 3M Innovative Properties Company Emulsifier free aqueous emulsion polymerization to produce copolymers of a fluorinated olefin and hydrocarbon olefin
US6956085B2 (en) * 2003-02-14 2005-10-18 3M Innovative Properties Company Fluoroelastomer compositions
EP1454740B1 (de) * 2003-03-04 2006-02-08 3M Innovative Properties Company Verfahren zur Verbindung von einer Fluoroelastomerschicht mit einer Silikonelastomerschicht, Laminat und Artikel davon
RU2383557C2 (ru) * 2003-06-09 2010-03-10 3М Инновейтив Пропертиз Компани Плавкая полимерная композиция, содержащая фторполимер, имеющий длинные боковые цепочки
WO2005066218A1 (en) * 2003-12-30 2005-07-21 3M Innovative Properties Company Fluoropolymer coagulation method and composition
ITMI20040830A1 (it) * 2004-04-27 2004-07-27 Solvay Solexis Spa Fluoroelastomeri vulcanizzabili
DE602004017604D1 (de) * 2004-09-09 2008-12-18 3M Innovative Properties Co Fluoropolymer zur Herstellung von einem Fluoroelastomer
US7402630B2 (en) * 2004-12-16 2008-07-22 3M Innovative Properties Company Curing compositions for fluoropolymers
US7294677B2 (en) * 2005-08-25 2007-11-13 3M Innovative Properties Company Catalyst for making fluoroelastomer compositions and methods of using the same
US7164041B1 (en) 2005-11-17 2007-01-16 3M Innovative Properties Company Fluorinated Gemini surfactants
JP2010514913A (ja) * 2007-01-03 2010-05-06 ソルヴェイ・ソレクシス・インコーポレーテッド フルオロエラストマー組成物
WO2009036131A2 (en) * 2007-09-14 2009-03-19 3M Innovative Properties Company Ultra low viscosity iodine containing amorphous fluoropolymers
US20100069554A1 (en) * 2008-09-18 2010-03-18 Dupont Performance Elastomers L.L.C. Curable fluoropolymer compositions
US7964001B2 (en) 2009-04-14 2011-06-21 Dupont Performance Elastomers L.L.C. Fuel management systems having a fluororubber article in contact with biodiesel fuel
WO2010147815A2 (en) 2009-06-19 2010-12-23 3M Innovative Properties Company Low temperature curable amorphous fluoropolymers
JP5547807B2 (ja) 2009-06-25 2014-07-16 スリーエム イノベイティブ プロパティズ カンパニー フルオロポリマー用の硬化組成物
TWI523900B (zh) 2010-07-20 2016-03-01 首威索勒希斯股份有限公司 氟彈性體組合物
US8309641B2 (en) 2010-08-13 2012-11-13 E I Du Pont De Nemours And Company Curable fluoroelastomer compositions
US8227535B2 (en) 2010-12-07 2012-07-24 E I Du Pont De Nemours And Company Polyhydroxy curable fluoroelastomer compositions
GB201108963D0 (en) 2011-05-27 2011-07-13 3M Innovative Properties Co Composite materials comprising polyamides and fluoroelastomers
EP2557109B1 (de) 2011-08-11 2019-01-23 3M Innovative Properties Company Verfahren zum kleben einer fluorelastomerverbindung auf ein metallsubstrat mit funktionalen kohlenstoffen mit niedrigem molekulargewicht als klebebeschleuniger
US9102814B2 (en) 2011-12-15 2015-08-11 The Chemours Company Fc, Llc Polyhydroxy curable fluoroelastomer compositions
US20150328866A1 (en) 2012-12-18 2015-11-19 E. I. Du Pont De Nemours And Company Laminates of fluoroelastomer and heat-stabilized acrylate elastomer
CN104981508B (zh) 2013-02-07 2017-03-15 纳幕尔杜邦公司 多羟基可固化含氟弹性体组合物
JP2020504775A (ja) 2016-12-28 2020-02-13 スリーエム イノベイティブ プロパティズ カンパニー ケイ素含有ハロゲン化エラストマー
CN111511777B (zh) 2017-12-22 2024-01-30 3M创新有限公司 具有含硅表面层的过氧化物固化的卤化弹性体
CN111742004B (zh) 2018-02-19 2022-07-19 3M创新有限公司 可固化组合物
WO2019159067A1 (en) 2018-02-19 2019-08-22 3M Innovative Properties Company Curable fluoroelastomer composition
US20200369867A1 (en) 2018-02-19 2020-11-26 3M Innovative Properties Company Curable fluoroelastomer composition
US20210155774A1 (en) 2018-04-10 2021-05-27 3M Innovative Properties Company Blends of crosslinking agents for fluoroelastomers
US20210108101A1 (en) 2018-06-12 2021-04-15 3M Innovative Properties Company Fluorinated polymer coating compositions and articles therefrom
EP3807355B1 (de) 2018-06-13 2022-04-27 3M Innovative Properties Company Härtbare fluorelastomerzusammensetzung
EP3837309A1 (de) 2018-08-13 2021-06-23 3M Innovative Properties Company Härtbare fluorelastomerzusammensetzung
CN113939557B (zh) 2019-06-06 2023-08-18 3M创新有限公司 包含含邻苯二甲腈和亲核官能团的化合物的可固化含氟聚合物组合物及由其制得的固化制品
WO2020261088A1 (en) 2019-06-28 2020-12-30 3M Innovative Properties Company Hydroxy-functionalized triazine compounds. curable fluoropolymer compositions comprising such compounds and cured articles therefrom
CN114269844A (zh) 2019-08-27 2022-04-01 3M创新有限公司 包含金属氟化物颗粒的可固化含氟聚合物组合物及其制品
WO2024064108A1 (en) 2022-09-20 2024-03-28 The Chemours Company Fc, Llc Non-fluorinated resorcinol and hydroquinone analogs as curing agents for fluoroelastomers
WO2024064107A1 (en) 2022-09-20 2024-03-28 The Chemours Company Fc, Llc Fluorinated resorcinol and hydroquinone analogs as curing agents for fluoroelastomers
WO2024081314A1 (en) 2022-10-12 2024-04-18 The Chemours Company Fc, Llc Curable fluoroelastomer compositions and low-friction cured fluoroelastomers (fkm) formed therefrom

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3442664A (en) * 1966-04-26 1969-05-06 Minnesota Mining & Mfg Treating composition,method of treating and treated surfaces
US3518292A (en) * 1967-03-27 1970-06-30 Dow Corning Quaternary phosphonium silicon complexes
US4094911A (en) * 1969-03-10 1978-06-13 Minnesota Mining And Manufacturing Company Poly(perfluoroalkylene oxide) derivatives
US3876654A (en) * 1970-12-23 1975-04-08 Du Pont Fluoroelastomer composition
USB493537I5 (de) * 1973-10-16 1976-03-23
DK553478A (da) * 1977-12-14 1979-06-15 Montedison Spa Vulkaniserbare blandinger paa basis af vinylidenfluoridelastomere samt fremgangsmaade til vulkanisering af saadanne blandinger
US4233421A (en) * 1979-02-26 1980-11-11 Minnesota Mining And Manufacturing Company Fluoroelastomer composition containing sulfonium curing agents
US5086123A (en) * 1984-02-27 1992-02-04 Minnesota Mining And Manufacturing Company Fluoroelastomer compositions containing fluoroaliphatic sulfonamides as curing agents
US4535184A (en) * 1984-06-08 1985-08-13 E. I. Du Pont De Nemours And Company Tris(disubstituted amino)sulfonium perfluorocarbanion salts
JPS6121149A (ja) * 1984-07-09 1986-01-29 Daikin Ind Ltd 加硫成形用組成物
US4927887A (en) * 1984-09-21 1990-05-22 Bridgestone/Firestone, Inc. Modified rubber compositions containing aromatic six-membered heterocyclic nitrogen-containing groups
US4828923A (en) * 1987-04-10 1989-05-09 Nippon Zeon Co., Ltd. Rubber laminates of fluororubber and nitrile rubber
US4882390A (en) * 1988-04-01 1989-11-21 Minnesota Mining And Manufacturing Company Fluoroelastomer composition with organo-onium compounds
US4912171A (en) * 1988-04-01 1990-03-27 Minnesota Mining And Manufacturing Company Fluoroelastomer curing process with phosphonium compound
CA1328533C (en) * 1988-04-01 1994-04-12 Werner Marie Aschille Grootaert Fluoroelastomer composition
JP2583444B2 (ja) * 1988-06-23 1997-02-19 日本ゼオン株式会社 ゴム積層体の製造方法
US5322904A (en) * 1988-09-28 1994-06-21 Exfluor Research Corporation Liquid-phase fluorination
US5384374A (en) * 1991-01-11 1995-01-24 Minnesota Mining And Manufacturing Company Curing fluorocarbon elastomers
JPH05339536A (ja) * 1992-06-11 1993-12-21 Minnesota Mining & Mfg Co <3M> フッ素ゴム塗布用組成物
US5262490A (en) * 1992-08-24 1993-11-16 Minnesota Mining And Manufacturing Company Fluoroelastomer composition with organo-onium compounds
US5274159A (en) * 1993-02-18 1993-12-28 Minnesota Mining And Manufacturing Company Destructable fluorinated alkoxysilane surfactants and repellent coatings derived therefrom

Also Published As

Publication number Publication date
AU1061797A (en) 1997-07-17
JP2000502389A (ja) 2000-02-29
EP0868477A1 (de) 1998-10-07
CA2238941C (en) 2006-10-03
US5591804A (en) 1997-01-07
DE69633135D1 (de) 2004-09-16
DE69633135T2 (de) 2005-09-08
CA2238941A1 (en) 1997-07-03
JP3723221B2 (ja) 2005-12-07
WO1997023556A1 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
EP0868477B1 (de) Fluorierte oniumsatze, härtbare zusammensetzungen, welche selbige enthalten, und härtungsverfahren unter deren verwendung
KR100516575B1 (ko) 저온 특성이 양호한 퍼플루오로에테르를 함유하는 플루오로엘라스토머
US5734085A (en) Fluorinated phosphonium salts
US5728773A (en) Fluoroelastomer composition with organo-onium and blocked-carbonate compounds
US6890995B2 (en) Fluoropolymer compositions
US6887927B2 (en) Fluoropolymer compositions containing a nitrogen cure site monomer and a sulfone or sulfoxide compound
EP1683837B1 (de) Fluorelastomer und vernetzbare Zusammensetzung daraus
EP0466340B1 (de) Härten von Fluorkohlenstoffelastomeren
US5654375A (en) Fluoroelastomer compositions containing organo-onium compounds
WO1997045480A1 (en) Fluoroelastomer compositions
WO2002083756A1 (en) Fluoropolymer compositions
EP2776498B1 (de) Härtbare zusammensetzungen für fluorpolymere
EP0847418B1 (de) Härtbare zusammensetzungen und härtungsmethode unter deren verwendung
CA2345460A1 (en) Fluororubber mixtures made fast crosslinkable fluororubbers
CA2384809A1 (en) Fluoropolymer composition with organo-onium and blocked oxalate compounds
JP2000503637A (ja) フッ素化ホスホニウム塩
JPS62138547A (ja) 含フツ素エラストマ−組成物
JP3887844B2 (ja) 含フッ素共重合体エラストマー組成物

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980717

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

17Q First examination report despatched

Effective date: 20020703

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB IT

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69633135

Country of ref document: DE

Date of ref document: 20040916

Kind code of ref document: P

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20050512

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20071128

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20071128

Year of fee payment: 12

Ref country code: FR

Payment date: 20071119

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20071221

Year of fee payment: 12

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20081126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081126

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20090731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090603

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081130